GLP-1 receptor agonists (GLP-1s) and SGLT-2 inhibitors lower the risk of major cardiovascular events like heart attacks and severe liver complications compared to other diabetes treatments, according ...
(WKBN) – Every year, thousands of people die from overdosing on opioids in the U.S. but now there’s a new, non-opioid pain medication that’s just been approved by the FDA. Suzetrigine is the first ...
Blood pressure medications have long been prescribed primarily for cardiovascular health, but emerging evidence suggests certain classes of these drugs may offer remarkable cognitive benefits for ...
First-in-class drugs can be highly innovative because of their novel mechanisms of action, but they also carry uncertainty in the absence of clinical experience. To understand how such drugs advance ...
RxPass subscription program increased medication adherence, with a 27% rise in days' supply and a 29% increase in prescription refills. Out-of-pocket costs for program medications decreased by 30%, ...
Adults recovering from surgery now have access to a pain drug that works through an entirely different biological mechanism than opioids. The FDA approved JOURNAVX, the brand name for suzetrigine, as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results